Affiliation:
1. Fresenius Medical Care
2. Global Medical Office - Fresenius Medical Care
3. EMEA Chief Clinical Officer, Global Medical Office – Clinical Affairs, CoE Clinical & Therapeutic Governance - Fresenius Medical Care Deutschland GmbH
Abstract
Abstract
Rationale & Objective.
End-stage kidney disease (ESKD) negatively affects patients’ physical, emotional, and social functioning. Furthermore, adjustment to dialysis require substantial lifestyle changes that may further impact on patients physical and emotional well-being. However, the relationship between Health-Related Quality of life impairment with future adverse outcomes in dialysis is not well characterized. Our study aims to investigate the relationship between Health-Related Quality of Life (HRQoL) and patients' survival and hospitalization rates within a large European dialysis network.
Methods
A historical cohort study was conducted to evaluate hospitalization and mortality rates over a 12-month follow-up period. Patients responded to a self-administered survey as part of a Continuous Quality Improvement Program implemented in clinics affiliated with the Spanish FMC-Nephrocare organization. Health-Related Quality of Life (HRQoL) was measured with the KDQOL-36. Potential confounders included socio-demographic characteristics, comorbidities, biochemical parameters, dialysis treatment. We used Cox's Proportional Hazard regression and Logistic regression to assess the likelihood of mortality and hospitalization within the 12-month follow-up period.
Results.
A total of 2280 (51.5%) completed the self-administrated survey, and 1838 patients met the inclusion/exclusion criteria of the study. Higher HRQoL scores were associated with significantly lower mortality and hospitalization risk. Risk estimates were robust to adjustment for potential confounders.
Conclusions.
Several dimensions of HRQoL are associated with patient-centered outcomes (i.e., mortality and hospitalizations at 1 year). Patient-Reported Outcomes contribute unique pieces of information characterizing patients’ health. residual confounding cannot be fully ruled out; selection due to high attrition rate may limit generizability.
Publisher
Research Square Platform LLC